朝鲜蓟提取物(Artichoke extract)

概要

基本信息

药物类型

中药

别名-

靶点-

作用方式-

作用机制-

治疗领域

肿瘤呼吸系统疾病其他疾病

在研适应症-

非在研适应症

石棉肺间皮瘤

原研机构

Aboca S.p.A. Società Agricola

在研机构-

非在研机构

Aboca S.p.A. Società Agricola

最高研发阶段无进展临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与朝鲜蓟提取物相关的临床试验

DRKS00024706

/ CompletedN/AIIT

A randomised, placebo-controlled, single blind, monocentric trial to investigate the influence of an artichoke leaf extract for the treatment of non-alcoholic fatty liver disease (NAFLD) - SteatoChoke

开始日期2022-11-01

申办/合作机构

Universität des Saarlandes

NCT02076672

/ Completed临床2期IIT

Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population (The ABOCA Phase II Trial)

This is a single-arm phase II trial to assess the biological activity (in a sub-cohort using a Simon two-stage Phase II design) and toxicity of Artichoke Whole Phytocomplex Concentrate (WPC). The objective of the study is to explore the potential for a non-toxic phytocomplex extract from the artichoke plant as a chemoprevention agent.

开始日期2019-11-05

申办/合作机构

Ontario Clinical Oncology Group

[+1]

100 项与朝鲜蓟提取物相关的临床结果

登录后查看更多信息

100 项与朝鲜蓟提取物相关的转化医学

登录后查看更多信息

100 项与朝鲜蓟提取物相关的专利（医药）

登录后查看更多信息

100 项与朝鲜蓟提取物相关的药物交易

登录后查看更多信息